Showing results (521-530 of 605) with videos related to

Sort By:
Pageof 61
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 26, 2025
Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year windowYara Yakoub, Fernando Gonzalez-Ortiz, Nicholas J Ashton, et al.
Physical Review Letters|November 6, 2020
Origin of Antibunching in Resonance FluorescenceLukas Hanschke, Lucas Schweickert, Juan Camilo López Carreño, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 4, 2026
Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's diseaseZeyu Zhu, Anna Steward, Amir Dehsarvi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adultsYara Yakoub, Fernando Gonzalez-Ortiz, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2025
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's diseaseAntoine Leuzy, Ariane Bollack, Daniela Pellegrino, et al.
JAMA Network Open|May 23, 2022
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic SymptomsArvid Edén, Anna Grahn, Daniel Bremell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 25, 2024
Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary MeasureRobel K Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, et al.
The Journal of Infectious Diseases|October 24, 2023
COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID ComplicationsNelly Kanberg, Anna Grahn, Erika Stentoft, et al.
The Lancet. Healthy Longevity|September 2, 2023
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort studyCatarina Tristão-Pereira, Valentin Fuster, Belen Oliva, et al.
Brain : a Journal of Neurology|September 18, 2025
Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's diseaseJulia Pescoller, Anna Dewenter, Amir Dehsarvi, et al.
Pageof 61